Facebook Twitter Instagram linkedin YouTube

Doctor Profile - Dr. R. Radhakrishnan

Senior Consultant & Hocs
Dr. R. Radhakrishnan


M.B.B.S, M.S., MCh( Vascular )., MRCS, Dip.N.B

Area(s) of Specialization:

Vascular surgeron


12 years after M.Ch (Vascular surgery)

Consultation days:

Monday to Saturday

Consultation Time:

8.00 am to 3.00 pm

For Appointment, Call:

044 - 45928505 EXT: 599

Fellowships / Memberships:

1 year in Queen Elizabeth Hospital, Birmingham UK


  • “Composite sequential bypass using profunda vein hitchhike”. Journal of Vascular Surgery
  • “Iatrogenic arteriovenous fistula unveiling aberrant left renal vein”- Journal of Vascular Surgery
  • “An unusual variant of Klippel – Trenaunay syndrome”- International Surgery Journal
  • “A RARE CASE OF BASILIC VEIN ANEURYSM”.- Indian Journal Of Medical Case
  • “Long – Term Follow – Up of Autologous Bone Marrow Cell Therapy: A Randomized Controlled Double – Blind Study for No – Option CLI” - Journal of Vascular Surgery
  • “Early results and lessons learned from a multicentre, randomized double – blind trial of bone marrow aspirate concentrate in critical limb ischemia” - Journal of Vascular Surgery
  • “Safety and Efficiacy of Rapid Autologous Bone Marrow Aspirate Concentrate for the Treatment of Critical Limb Ischemia in Buerger’s Disease” - Journal of Vascular Surgery


  • “Safety and Efficacy of Dexadine ( cadexomer iodine) in the treatment of chronic wounds”
  • “Feasibility Study of the Safety and Activity of Autologous Bone Marrow Aspirate Concentrate (BMAC) For the Treatment of Non Reconstructable Critical Limb Ischemia Due To Peripheral Arterial Occlusive Disease”
  • “A Phase II, Randomized, Prospective, Double blind, Parallel group, Multi-Center Study to Determine the Safety and Efficacy of GRANEXIN GEL in the Treatment of Venous Leg Ulcer”.
  • A Non-Randomized, Open Label, Multicentric, Dose Ranging, Phase II Study Assessing the Efficacy and Safety of Intramuscular Administration of Stempeucel- CLITM (Ex Vivo Cultured Adult Bone Marrow Derived Allogeneic Mesenchymal Stem Cells) in Patients with Critical Limb Ischemia due to Buerger’s Disease”.

Other Consultants in Vascular Surgery

Vascular Surgery

Direct:044-45928505 (8am-4pm) Board:044-45928500

Ext.no. 599 / 444 / 8626

Map & Direction